InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Monday, 12/12/2016 12:47:20 PM

Monday, December 12, 2016 12:47:20 PM

Post# of 458
Friday 12/9 Clearside Biomedical analyst commentary at Wedbush Clearside Biomedical selloff not based on fundamentals, says Wedbush. Wedbush analyst Liana Moussatos believes the selloff today in shares of Clearside Biomedical is based on investor sentiment and not fundamentals. The company's clinical data "so far has been excellent," Moussatos tells investors in a research note with Clearside shares down 19% to $9.29. She views the selloff as a buying opportunity and keeps an Outperform rating on the shares with a $28 price target. Read more at: http://thefly.com/landingPageNews.php?id=2475160

Read more at:
http://thefly.com/landingPageNews.php?id=2475160
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLSD News